Inactive Instrument

News Profound Medical Corp Toronto S.E.

Equities

PRN

CA74319B1067

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

Mar. 13	Transcript : Profound Medical Corp. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
Mar. 11	Alliance Global Partners Trims Price Target on Profound Medical to $10.80 From $12.75, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	Apr. 22	AQ
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 09	AQ
Transcript : Profound Medical Corp. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM	Mar. 13
Alliance Global Partners Trims Price Target on Profound Medical to $10.80 From $12.75, Maintains Buy Rating	Mar. 11	MT
Stifel Adjusts Price Target on Profound Medical to $9 From $11, Keeps Hold Rating	Mar. 08	MT
Profound Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Transcript : Profound Medical Corp., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment	Mar. 07	MT
Profound Medical Brief: Announcing promotion of Mathieu Burtnyk, from SVP Product Leader to Chief Operating Officer	Mar. 07	MT
Profound Medical Brief: Q4 2023 net loss was approximately US$8.9 million, or $0.42 per common share	Mar. 07	MT
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 07	AQ
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	Mar. 07	DJ
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	Mar. 04	AQ
Profound Medical Collaborates With Siemens Healthineers to Expand Physician and Patient Access to the TULSA Procedure	Feb. 27	MT
Profound Medical Corp. Enters into A Non-Exclusive Collaboration with Siemens Healthineers	Feb. 27	CI
Profound Medical Brief: Entering Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	Feb. 27	MT
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	Feb. 27	AQ
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	Feb. 15	AQ
Profound Medical Up 1.9% In US After Hours As Announces Non-Brokered Private Placement	Jan. 16	MT
Profound Medical Announces Non-Brokered Private Placement	Jan. 16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Profound Medical Corp Toronto S.E.

Equities

PRN

CA74319B1067

Summary

Filters